PURPLE BIOTECH LTD.
PPBT · XNASCIK 1614744fmd_1BPNE5B028991204FGPBSQ0CPGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2025, 14 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | 1 | 1 | 1 | – | – | – | – | – |
| Research and development | 4 | 5 | 5 | 2 | 7 | 12 | 16 | 17 | 8 | 4 |
| Selling, general and administrative | 3 | 6 | 5 | 4 | 6 | 6 | 6 | 5 | 3 | 3 |
| Operating income | (7) | (12) | (8) | (7) | (13) | (18) | (23) | (22) | – | – |
| Interest expense | 0 | 0 | 1 | 0 | 0 | (0) | 0 | 2 | 0 | 1 |
| Income tax expense | – | – | – | 0 | – | – | – | – | – | – |
| Net income from continuing operations | (12) | (13) | (6) | (5) | 29 | 18 | 22 | 20 | 7 | 26 |
| Net income | 12 | 12 | 5 | 6 | 28 | 18 | (22) | (20) | (7) | (26) |